Bill Few Associates’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$243K Buy
6,010
+23
+0.4% +$1.03K 0.05% 210
2026
Q2
$279K Buy
5,987
+18
+0.3% +$833 0.06% 194
2026
Q1
$293K Buy
5,969
+18
+0.3% +$837 0.07% 169
2025
Q4
$259K Buy
5,951
+15
+0.3% +$685 0.06% 178
2025
Q3
$267K Buy
5,936
+469
+9% +$20.6K 0.07% 166
2025
Q2
$237K Buy
5,467
+7
+0.1% +$312 0.07% 169
2025
Q1
$252K Buy
+5,460
New +$228K 0.09% 151
2024
Q4
– Sell
-5,085
Closed -$206K – 180
2024
Q3
$206K Buy
+5,085
New +$191K 0.07% 172
2024
Q2
– Sell
-5,366
Closed -$202K – 177
2024
Q1
$202K Buy
+5,366
New +$192K 0.08% 164
2022
Q1
– Sell
-4,906
Closed -$202K – 123
2021
Q4
$202K Buy
+4,906
New +$185K 0.1% 116

Other funds holding EXC

Bill Few Associates's EXC Position: Q3 2026 in Review

Bill Few Associates increased its Exelon (EXC) stake by 0.38% in Q3 2026, buying an estimated $1.03K and bringing the position to 6,010 shares worth $243K. The position accounts for 0.05% of the portfolio, ranked #210.

Bill Few Associates first reported a position in EXC in Q4 2021 and has held it in 10 quarters since. The position peaked at $293K in Q1 2026. 45 funds tracked by Wall St. Rank hold EXC as of Q3 2026.

  • Bill Few Associates held 6,010 shares of Exelon worth $243K as of Q3 2026.
  • Bill Few Associates bought 23 Exelon shares in Q3 2026, an estimated $1.03K.
  • Exelon made up 0.05% of Bill Few Associates's portfolio in Q3 2026, its #210 holding.
  • Bill Few Associates first reported a position in Exelon in Q4 2021 and has held it in 10 quarters since.
  • Bill Few Associates's Exelon position peaked at $293K in Q1 2026.
  • 45 funds tracked by Wall St. Rank held Exelon as of Q3 2026.

Based on Bill Few Associates's 13F filing for Q3 2026, filed 9 Oct 2026.